{"id":108,"date":"2005-04-05T00:40:46","date_gmt":"2005-04-05T00:40:46","guid":{"rendered":"http:\/\/michaelkrolczyk.com\/?p=108"},"modified":"2024-12-24T16:14:02","modified_gmt":"2024-12-24T16:14:02","slug":"more-on-aml-m3","status":"publish","type":"post","link":"https:\/\/michaelkrolczyk.com\/?p=108","title":{"rendered":"More on AML M3"},"content":{"rendered":"<p>My brother-in-law, Trey, found some great links on what I am going through.  Here is what he put together:<\/p>\n<p><a href=\"http:\/\/www.leukine.com\/patient\/276.html\">Understanding AML<\/a> &#8220;This has a good page with the types of AML, and the FAB classification table&#8221;  For example, it names the M3 type.<\/p>\n<p><a href=\"http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/adultAML\/patient\">General information about AML<\/a> (Acute Myeloid Leukemia) from cancer.gov (For patients)<\/p>\n<p><a href=\"http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/adultAML\/HealthProfessional\">Acute Myeloid Leukemia from cancer.gov<\/a> (For Health Professionals)<\/p>\n<p><a href=\"http:\/\/www.cancer.org\/docroot\/CRI\/content\/CRI_2_4_4x_Treatment_of_Acute_Promyelocytic_M3_Leukemia_AML.asp?sitearea=\">Treatment of Acute Promyelocytic (M3) Leukemia (AML)<\/a><\/p>\n<p>AP John institute for cancer research, <a href=\"http:\/\/www.apjohncancerinstitute.org\/cancer\/acutemy.htm\">AML Information<\/a><\/p>\n<p>There are TONs more, but they all pretty much say the same things.  The most important one to me was the Treatment of Acute Promy&#8230; page because it states a 70-90% cure rate for the all-trans retinoic acid (vitamin a relative) plus chemo treatment.<\/p>\n<p>Thanks Trey!  That treatment plan metioned is essentially the plan I will start going through later this morning.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>My brother-in-law, Trey, found some great links on what I am going through. Here is what he put together: Understanding AML &#8220;This has a good page with the types of AML, and the FAB classification table&#8221; For example, it names the M3 type. General information about AML (Acute Myeloid Leukemia) from cancer.gov (For patients) Acute &hellip; <a href=\"https:\/\/michaelkrolczyk.com\/?p=108\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">More on AML M3<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[133,132],"class_list":["post-108","post","type-post","status-publish","format-standard","hentry","category-leukemia","tag-acute-myelogenous-leukemia","tag-aml-m3"],"_links":{"self":[{"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=\/wp\/v2\/posts\/108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=108"}],"version-history":[{"count":1,"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=\/wp\/v2\/posts\/108\/revisions"}],"predecessor-version":[{"id":779,"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=\/wp\/v2\/posts\/108\/revisions\/779"}],"wp:attachment":[{"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/michaelkrolczyk.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}